Belgium· BE-AMP-SAM119926-00

Para Spray

A bioallethrin product containing allethrin i, registered in Belgium by Medgenix Benelux.

ATC P03AC02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedPara SprayATCP03AC02REGISTER NO.BE-AMP-SAM119926-00PACKS LISTED1CHECKEDSeptember 26, 2026

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Allethrin I
Manufacturer
Medgenix Benelux
Country
Belgium (BE)
ATC code
P03AC02
ATC class
Bioallethrin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0831446

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f1ba979f-d644-4512-a514-0813ae0ee865
GET /v1/drugs/f1ba979f-d644-4512-a514-0813ae0ee865?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Cutaneous spray, solution",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Para Spray",
  "name_fr": "Para Spray",
  "name_nl": "Para Spray",
  "amp_code": "SAM119926-00",
  "strengths": [
    "6.6000",
    "26.4000"
  ],
  "pack_count": 1,
  "substances": [
    "Allethrin I",
    "Piperonyl Butoxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Bioallethrin",
  "authorisation_numbers": [
    "BE119926"
  ]
}

See everything about bioallethrin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.